Browse diseases

…onsistent, transparent and comprehensive reporting in AI-driven oncology trials is essential to building trust in these promising techno…

…ting of randomised controlled trials (RCTs), including those in oncology.1 Due to the unique methodological and implementation challenge…

…ion-making (SDM) and advance care planning (ACP) are crucial in oncology for optimising patient-centred care, supporting families and im…

…nd analysis In the setting of globally based clinical trials in oncology drug development, two public databases (ClinicalTrials.gov and …

…n-making with clinicians for the provision of optimal precision oncology care for their patients. The implementation intervention is the…

…tors identified in phase one.Setting National and international oncology guideline development programmes using the LG development frame…

…sensitive approaches to introducing/discussing ACP into routine oncology care. Addressing these barriers is critical to reducing inequit…

…ent trust, engagement and clinical outcomes.While developed for oncology care, the benchmark principles are adaptable across diseases, o…

…y was to evaluate the impact of pharmaceutical consultations on oncology patients undergoing therapy with oral antineoplastic agents. A …

…ting of randomised controlled trials (RCTs), including those in oncology.1 Due to the unique methodological and implementation challenge…

…% antiretroviral therapy (ART). The breakdown by specialty was: dermatology (19%), oncology (18%), internal medicine (13%), and rheumatolog…

…CA/AA/EC). Most frequent therapeutic areas were Oncology (45%), Haematology (16%) and Cardiovascular (6%). Among oncology therapies, 44% ac…